Kynam Capital Management, LP Vaxcyte, Inc. Transaction History

Kynam Capital Management, LP

$1.19 Billion
Q1 2025

A detailed history of Kynam Capital Management, LP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 3,200,000 shares of PCVX stock, worth $106 Million. This represents 10.18% of its overall portfolio holdings.

Number of Shares

3,200,000

Previous 2,336,796 36.94%

Holding current value

$106 Million

Previous $191 Million 36.83%

% of portfolio

10.18%

Previous 12.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$37.76 - $92.13 $32.6 Million - $79.5 Million	863,204 Added 36.94%	3,200,000 $121 Million
Q4 2024 Feb 14, 2025	BUY	$80.97 - $117.93 $105 Million - $153 Million	1,297,508 Added 124.85%	2,336,796 $191 Million
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $20.2 Million - $33.5 Million	286,048 Added 37.98%	1,039,288 $119 Million
Q2 2024 Aug 14, 2024	BUY	$60.06 - $78.77 $494,894 - $649,064	8,240 Added 1.11%	753,240 $56.9 Million
Q1 2024 May 15, 2024	SELL	$59.79 - $81.05 $15.4 Million - $20.9 Million	-257,407 Reduced 25.68%	745,000 $50.9 Million
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $13.6 Million - $19 Million	-300,000 Reduced 23.03%	1,002,407 $63 Million
Q3 2023 Nov 14, 2023	BUY	$46.0 - $53.1 $110,722 - $127,811	2,407 Added 0.19%	1,302,407 $66.4 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $2.88 Million - $4.5 Million	83,216 Added 6.84%	1,300,000 $64.9 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $18.6 Million - $24.2 Million	513,343 Added 72.98%	1,216,784 $45.6 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $98,845 - $230,303	4,803 Added 0.69%	703,441 $33.7 Million
Q3 2022 Nov 14, 2022	SELL	$21.69 - $28.53 $545,351 - $717,329	-25,143 Reduced 3.47%	698,638 $16.8 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $2.55 Million - $3.83 Million	144,141 Added 24.87%	723,781 $15.7 Million
Q1 2022 May 13, 2022	BUY	$17.46 - $26.36 $6.43 Million - $9.7 Million	368,157 Added 174.08%	579,640 $14 Million
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $4.09 Million - $5.59 Million	211,483 New	211,483 $5.03 Million

Others Institutions Holding PCVX

# of Institutions

345

Shares Held

136M

Call Options Held

348K

Put Options Held

250K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $1.97B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Account

Kynam Capital Management, LP Vaxcyte, Inc. Transaction History